Orchestra BioMed Holdings, Inc. Profile Avatar - Palmy Investing

Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (S…

Biotechnology
US, New Hope [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Competitors Table
Competitor Private? Source Accuracy Country City
- - - -
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of OBIO's Analysis
CIK: - CUSIP: 68572M106 ISIN: US68572M1062 LEI: - UEI: -
Secondary Listings
OBIO has no secondary listings inside our databases.